Clinical Trials Browser

Completed × Multiple Myeloma × Idarubicin × Clear all

NCT00006232 2013-05-15

Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell